Effect of Tetracaine on Pain Management and Corneal Healing in Patients With Acute Corneal Abrasion

NCT02483897 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped inabililty to recruit at required rate

Conditions

Corneal Abrasion

Interventions

DRUG: Tetracaine 0.5% ophthalmic drops
DRUG: Normal Saline placebo drops

Sponsor

Queen's University